IMMUNEONCO-B (01541) Results Announcements
| Date | Type | Title | Filing |
|---|---|---|---|
| 2026-08-26 | Interim Results | INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | |
| 2026-08-14 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2026-03-25 | Final Results | ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 | |
| 2026-03-13 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2025-08-26 | Interim Results | INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | |
| 2025-08-12 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2025-03-25 | Final Results | ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 AND PROPOSED CHANGE IN USE OF PROCEEDS | |
| 2025-03-13 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2024-08-26 | Interim Results | ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 | |
| 2024-08-14 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2024-03-25 | Final Results | ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 | |
| 2024-03-13 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2023-09-26 | Interim Results | ANNOUNCEMENT INTERIM REPORT FOR THE SIX MONTHS ENDED JUNE 30, 2023 |
Sourced from HKEXnews. Hong Kong does not mandate quarterly reporting — most issuers file interim and final results only. Profit warnings and board meeting dates are included as pre-results signals.